Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disordersStrategic Application of Residence-Time Control in Continuous-Flow ReactorsDihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.Novel Pyridazinone Inhibitors for Vascular Adhesion Protein-1 (VAP-1): Old Target–New Inhibition ModeChanging the face of kynurenines and neurotoxicity: therapeutic considerationsPeptidic foldamers: ramping up diversityLiquid-phase combinatorial synthesis of alicyclic beta-lactams via Ugi four-component reaction.Comparison of column performances in direct high-performance liquid chromatographic enantioseparation of 1- or 3-methyl-substituted tetrahydroisoquinoline analogs. Application of direct and indirect methods.Synthesis of conformationally constrained tricyclic beta-lactam enantiomers through Ugi four-center three-component reactions of a monoterpene-based beta-amino acid.Stabilisation of Peptide foldamers in an aqueous medium by incorporation of azapeptide building blocks.N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats.Physiological role of salsolinol: its hypophysiotrophic function in the regulation of pituitary prolactin secretion.High-performance liquid chromatographic enantioseparation of naphthol-substituted tetrahydroisoquinolines on polysaccharide-based chiral stationary phases.High-performance liquid chromatographic enantioseparation of Betti base analogs on a newly developed isopropyl carbamate-cyclofructan6-based chiral stationary phaseComparison of performance of Chirobiotic T, T2 and TAG columns in the separation of beta2- and beta3-homoamino acids.Side-chain control of beta-peptide secondary structures.Stereoselective synthesis and cytoselective toxicity of monoterpene-fused 2-imino-1,3-thiazines.High-performance liquid chromatographic enantioseparation of amino alcohol analogues possessing 1,2,3,4-tetrahydroisoquinoline skeleton on polysaccharide-based chiral stationary phases.High-performance liquid chromatographic enantioseparation of fluorinated cyclic β(3) -amino acid derivatives on polysaccharide-based chiral stationary phases. Comparison with nonfluorinated counterparts.Syntheses of hydroxylated cyclic beta-amino acid derivatives.Application of alicyclic beta-amino acids in peptide chemistry.Efficient continuous-flow synthesis of novel 1,2,3-triazole-substituted β-aminocyclohexanecarboxylic acid derivatives with gram-scale productionThe role of the Na+/Ca2+ exchanger, I(Na) and I(CaL) in the genesis of dofetilide-induced torsades de pointes in isolated, AV-blocked rabbit hearts.High-performance liquid chromatographic chiral separation of beta2-homoamino acids.Exenatide induces aortic vasodilation increasing hydrogen sulphide, carbon monoxide and nitric oxide production.Monoterpene-based chiral β-amino acid derivatives prepared from natural sources: syntheses and applications.Synthesis of carbocyclic and heterocyclic β-aminocarboxylic acids.Novel kynurenic acid analogues in the treatment of migraine and neurodegenerative disorders: preclinical studies and pharmaceutical design.An overview of peptide and peptoid foldamers in medicinal chemistry.Homochirality of β-Peptides: A Significant Biomimetic Property of Unnatural Systems.Brain Aging and Disorders of the Central Nervous System: Kynurenines and Drug Metabolism.Excitotoxic Mechanisms in Non-Motor Dysfunctions and Levodopa- Induced Dyskinesia in Parkinson's Disease: The Role of the Interaction Between the Dopaminergic and the Kynurenine System.An overview of peptide and peptoid foldamers in medicinal chemistry.Migraine, neurogenic inflammation, drug development - pharmacochemical aspects.Highly functionalized cyclic β-amino acid moieties as promising scaffolds in peptide research and drug design.ATP-binding cassette B1 transports seliciclib (R-roscovitine), a cyclin-dependent kinase inhibitor.Effects of the alternating backbone configuration on the secondary structure and self-assembly of beta-peptides.Synthesis and multidrug resistance reversal activity of 1,2-disubstituted tetrahydroisoquinoline derivatives.Induced folding of protein-sized foldameric β-sandwich models with core β-amino acid residues.Enzymatic Strategy for the Resolution of New 1-Hydroxymethyl Tetrahydro-β-carboline Derivatives in Batch and Continuous-Flow Systems
P50
Q21710687-26FD8F11-2A5A-4D7C-B527-6E45F3265389Q26801617-7CBB40D8-935B-412C-AFDA-36DACEED966FQ27333755-F57A510D-3C54-4054-81C3-DAB340FF25ABQ27680757-9478A694-ECF8-434D-9835-DDB423322685Q28085041-A797B55D-8689-45D6-A8BE-DD3394D4747DQ29030928-BDA37B17-C2F0-4106-BF88-540FC1D5DB21Q31061476-2574E305-E75A-4F81-ACFE-B1F83FF0BF41Q31164183-9AF17E90-C724-4222-B105-8F1209D329BEQ33430283-9AE32B16-1A4B-4A87-9D4E-DEE67E3C60B8Q33502247-95A82D82-8B4A-42C6-B6A0-EE7566CE20CCQ34337749-2D2297F9-D328-40AF-BBEE-2916D2F3F74DQ34802119-7B0D029C-4D55-43C3-9190-CA0A12576C54Q34880130-9A3A0DBF-C0BF-49AA-9F06-296002BC6882Q35013100-90A6D43C-176E-414F-8DE4-69B58359B427Q35013135-A073CC47-6AEF-4BD6-98B0-A4FD3150B041Q35209610-C889104A-1900-4B1B-88AD-16B7075EA72FQ35298689-3EEB17FF-FD73-4A91-A1BF-B7675DF0499BQ35360106-D814371F-0CA4-4B47-9708-6754735F9631Q35923183-01A67CC4-0888-4878-A53A-FDEF0A210F02Q36352280-BD35FA5D-5B0F-4F5B-AF2F-4C1F813A4610Q36432369-43FD33CE-B5A6-4F76-859A-B72B2014FACFQ37088102-99A9E893-7DBC-4851-99C6-10B1AD7A86BFQ37230746-3824A49E-EBA6-4B18-B259-503071E45F08Q37315700-4AB573FB-0C2E-413C-8129-2C07573BA72BQ37686091-4DA029A7-17A4-492D-A1C9-49C059DFFD16Q37859312-1265283A-CF77-4743-BCFF-0775F986CCA8Q38168284-24689692-CC29-4C37-80B1-173AA61B704BQ38306955-0B6357A1-525A-457F-890C-BB3078E851BFQ38569751-6ABD6346-386D-40C1-95F6-D12830532609Q38644625-7BCC2F3C-BCF6-47C8-9A12-2328C8D42C99Q38676394-69C91EF5-964D-4231-96CF-76717D34FBCDQ38731627-BF840B86-DA5C-4DD8-8F87-93007B73E268Q38976039-62568362-8763-4778-89D5-926AEFCC9EB1Q39152900-9C0A16BC-D9F9-4DF2-8319-40E7847305C1Q39387421-57DCD6C9-53EF-4CED-8355-4BDF387DC95DQ39668909-352BB518-1D67-40C5-88D3-B76975D7E2E6Q40280517-57B6C946-05BB-4EFC-83C7-0F205BDA28D9Q40531617-12113EC2-AB37-45D7-B94B-4FCC46A9CF09Q41442763-B96979BC-AC27-4860-82E6-D8DF6B443B50Q41900499-9014407C-667C-4A59-82DC-6B069C172B4B
P50
description
Hongaars hoogleraar
@nl
Hungarian university teacher and chemist
@en
chimiste hongrois
@fr
magyar kémikus, az MTA rendes tagja
@hu
name
Ferenc Fulop
@sq
Ferenc Fülöp (kemiisto)
@eo
Ferenc Fülöp
@ast
Ferenc Fülöp
@en
Ferenc Fülöp
@es
Ferenc Fülöp
@fr
Ferenc Fülöp
@ga
Ferenc Fülöp
@nl
Ferenc Fülöp
@sl
Fülöp Ferenc
@hu
type
label
Ferenc Fulop
@sq
Ferenc Fülöp (kemiisto)
@eo
Ferenc Fülöp
@ast
Ferenc Fülöp
@en
Ferenc Fülöp
@es
Ferenc Fülöp
@fr
Ferenc Fülöp
@ga
Ferenc Fülöp
@nl
Ferenc Fülöp
@sl
Fülöp Ferenc
@hu
altLabel
Ferenc Fulop
@nl
Ferenc Fülöp
@sq
prefLabel
Ferenc Fulop
@sq
Ferenc Fülöp (kemiisto)
@eo
Ferenc Fülöp
@ast
Ferenc Fülöp
@en
Ferenc Fülöp
@es
Ferenc Fülöp
@fr
Ferenc Fülöp
@ga
Ferenc Fülöp
@nl
Ferenc Fülöp
@sl
Fülöp Ferenc
@hu
P166
P19
P21
P2492
P27
P31
P3973
P569
1952-02-23T00:00:00Z